International Journal of Vaccines

Medical Sciences ISSN 3048-5681 2 issues a year Hybrid open access

Submit a manuscript Search this journal Editorial board (7)

About the journal

International Journal of Vaccines is a peer-reviewed open-access journal launched in 2024 that focuses on the International Journal of Vaccines was on all facets of vaccine research. It explains the complex characteristics of atypical disease symptoms followed by chronic disease development, whose diagnosis results in the discovery of novel aspects or mechanisms in the pathology of that disease boosting the immune system, the body & natural system for combating disease.

View full aims and scope →

Journal metrics

Counted from this archive, not supplied by anyone.

  • 29Articles published
  • 7Published in 2026
  • 82Authors
  • 0Open access

Journal information

Title
International Journal of Vaccines
Issues per year
2 issues
ISSN
3048-5681
Publisher
STM Journals
DOI
10.37591/IJV
Starting year
2024
Subject
Medical Sciences
Publication format
Hybrid open access
Language
English
Type
Peer-reviewed journal (refereed)
Article processing charge
$800

Editorial board

  • Editor-in-Chief

    Dr. Amit Awasthi

    Biotechnology, Translational Health Science & Technology Institute, India

All 7 board members →

Latest articles

  • Published Subscription Review Article

    ML Analysis of Factors Affecting Vaccination in Rural Children: A Machine Learning Approach

    Abstract: Vaccination remains one of the most effective public health interventions for preventing childhood diseases, yet rural regions in India continue to experience uneven immunization coverage due to multiple socioeconomic and geographic barriers. This research applies machine learning techniques to identify and analyze the major determinants influencing childhood vaccination uptake in rural communities. The study utilizes survey-based demographic, socioeconomic, and healthcare-related parameters to build predictive models that classify children as vaccinated …

    Published in International Journal of Vaccines · Vol. 3, Issue 2, 2026 Read article

  • Published Subscription Review Article

    Next-Generation mRNA Vaccines: Applications Beyond COVID-19

    Abstract: Messenger RNA (mRNA) vaccine technology has become a paradigm shift in contemporary medicine and, with remarkable success in the COVID-19 pandemic, has opened the door to a new wave of vaccines development. In contrast to the traditional vaccine methods, mRNA vaccines are based on the synthetic genetic code that allows host cells to express target antigens, thus eliciting strong humoral and cellular immunity. The speed of development, efficacy, scalability of …

    Published in International Journal of Vaccines · Vol. 3, Issue 2, 2026 · pp. 15–26 Read article

  • Published Subscription Review Article

    Impact of Vaccine Awareness Campaigns on Pharmacovigilance Reporting and Public Safety Monitoring

    Abstract: Vaccination programs have significantly contributed to the reduction of infectious diseases worldwide; however, their success is closely tied to public confidence and robust safety monitoring systems. Pharmacovigilance plays a critical role in identifying, assessing, and preventing adverse events following immunization (AEFI). In recent years, vaccine awareness campaigns have emerged as a pivotal strategy to improve public knowledge, reduce vaccine hesitancy, and enhance reporting of adverse drug reactions (ADRs). This review …

    Published in International Journal of Vaccines · Vol. 3, Issue 2, 2026 · pp. 1–14 Read article

  • Published Subscription Review Article

    Early Life Nutrition as a Determinant of Long-Term Vaccine Immunogenicity in Livestock: Mechanisms, Practical Strategies, and Species-Specific Considerations

    Abstract: Early life represents a critical period for immune system development in livestock, during which nutritional exposures can exert long lasting effects on vaccine immunogenicity. Although vaccination is a cornerstone of infectious disease control in food producing animals, marked variability in vaccine induced immune responses is frequently observed under commercial conditions. Growing evidence suggests that this variability is partly driven by differences in early nutritional status, which can influence immune maturation, …

    Published in International Journal of Vaccines · Vol. 3, Issue 1, 2026 · pp. 15–26 Read article

  • Published Subscription Review Article

    Role of Pharmaceutical Software in Vaccine Development and Manufacturing Process Optimization

    Abstract: Vaccine development and manufacturing have become increasingly complex due to the emergence of diverse vaccine platforms, stringent regulatory expectations, and global demand for safe and effective immunization. Across the vaccine lifecycle – from antigen design and preclinical evaluation to large‑scale manufacturing and post‑marketing surveillance – pharmaceutical software now plays a central role in handling data, optimizing processes, and ensuring regulatory compliance. Software tools support in silico antigen and epitope design, …

    Published in International Journal of Vaccines · Vol. 3, Issue 1, 2026 · pp. 1–8 Read article

  • Published Subscription Review Article

    The future of global immunisation strategies: an examination of vaccines

    Abstract: Vaccination is still one of the best ways to improve public health, but worldwide immunization plans are facing new scientific, societal, and logistical problems. This article looks at the future of global immunization programs by looking at present and new vaccine technology, delivery systems, and policy frameworks. It looks at new technologies including mRNA platforms, thermostable vaccines, and new ways to distribute vaccinations that could help more people get them …

    Published in International Journal of Vaccines · Vol. 3, Issue 1, 2026 · pp. 9–14 Read article

  • Published Subscription Review Article

    Ebola Vaccination: From Outbreak Control to Global Preparedness

    Abstract: Ebola virus disease (EVD) is one of the most dreadful and lethal viral infections, continuously generating threatening impacts on the health of the global population, especially in low-resource environments. This review provides an overview of Ebola vaccines, focusing on virology, vaccine development, clinical trials, regulatory approval, deployment plans, and ethical issues. Recombinant viral vector platforms have seen the development of successful vaccines, with the most prominent example being rVSV-ZEBOV, which …

    Published in International Journal of Vaccines · Vol. 3, Issue 1, 2026 · pp. 27–37 Read article

  • Published Subscription Review Article

    A Decade of Viral Evolution (2015–2025): Emergence, Mutations, and Implications for Global Health

    Abstract: Over the past decade (2015-2025), viral evolution has profoundly reshaped the global health landscape, challenging healthcare systems, diagnostic tools, therapeutic strategies, and vaccine efficacy. This review comprehensively analyzes the evolutionary trajectories of major human and zoonotic viruses, with a focus on pandemic-prone, drug-resistant, and emerging pathogens. Viral evolution is driven by diverse molecular mechanisms including high mutation rates, recombination, reassortment, host immune pressure, and antiviral interventions, leading to genetic diversification, …

    Published in International Journal of Vaccines · Vol. 2, Issue 2, 2025 · pp. 31–40 Read article

All 29 articles in this journal →

Archive

Volume 3 (2026)

Volume 2 (2025)

Volume 1 (2024)